Lifecore Biomedical, Inc. LFCR Tax on Share Settlement
Tax on Share Settlement at other companies
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s tax on share settlement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s tax on share settlement?
- Lifecore Biomedical, Inc. (LFCR) reported tax on share settlement of $0 in Q1 2026.
- How has Lifecore Biomedical, Inc.'s tax on share settlement changed year-over-year?
- Lifecore Biomedical, Inc.'s tax on share settlement decreased by 100.0% year-over-year, from $163K to $0.
- What is the long-term trend for Lifecore Biomedical, Inc.'s tax on share settlement?
- Over 3 years (2022 to 2025), Lifecore Biomedical, Inc.'s tax on share settlement has grown at a 17.2% compound annual growth rate (CAGR), from $789K to $1.27M.
- What does tax on share settlement mean?
- Cash paid to tax authorities for employee share vesting, where the company withholds shares and pays the tax obligation in cash.